FrederickRUelandMD
Obstetrics & Gynecology • Lexington, KYGeneral Obstetrics, Gynecologic Oncology
Professor
Dr. Ueland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Rose Street
Lexington, KY 40536Phone+1 859-257-1613- Is this information wrong?
Summary
- Dr. Frederick Ueland is Professor and Director of Gynecologic Oncology at the University of Kentucky Albert B. Chandler Hospital in Lexington, KY. He is also the Chief Medical Officer and Director of Clinical Operations for the Markey Cancer Center. He received his medical degree from Wake Forest School of Medicine and did a General Surgery Internship, Residency in Obstetrics and Gynecology, and Fellowship in Gynecologic Oncology at the University of Kentucky. He has been in practice 27 years. He specializes in gynecologic oncology with a specialty interest in ovarian cancer and comprehensive gynecologic surgery.
Education & Training
University of Kentucky College of MedicineResidency, Obstetrics and Gynecology, 1991 - 1995- University of Kentucky College of MedicineInternship, Surgery, 1990 - 1991
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1990
Stanford UniversityBS, Biology, honors degree, 1981 - 1985
University of Kentucky College of MedicineFellowship, Gynecologic Oncology
Certifications & Licensure
KY State Medical License 1991 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly
- Best Doctors in America Teladoc Health
- Top Doctors in America Castle Connolly
- Join now to see all
Clinical Trials
- Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
- Join now to see all
Publications & Presentations
PubMed
- Compelling Story of Ovarian Cancer Screening.Edward J Pavlik, John R van Nagell Jr, Charles S Dietrich 3rd, Frederick R Ueland> ;Journal of Clinical Oncology. 2024 Apr 1
- Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventi...Hutchcraft, M. G., Megan L Hutchcraft, Shulin Zhang, Nan Lin, Justine C Pickarski, Elizabeth A Belcher, Sainan Wei, Thèrése Bocklage, Rachel W Miller, John L Villano, ...> ;JCO Precision Oncology. 2024 Jan 1
- Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer.Laura M Harbin, Nan Lin, Frederick R Ueland, Jill M Kolesar> ;International Journal of Molecular Sciences. 2023 Sep 18
- Join now to see all
Journal Articles
- Proposal for a Risk-Based Categorization of Uterine CarcinosarcomaFrederick R Ueland, Esther Elishaev, Tanja Pejovic, Todd B Sheridan, Terry Morgan, Joseph L Kelley, Malcolm S Ross, Stephen H Bush, Ardeshir Hakam, Lynda D Roman, Meri..., Annals of Surgical Oncology
- Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine CarcinosarcomaLynda D Roman, Terry Morgan, Joseph L Kelley, Todd B Sheridan, Stephen H Bush, Merieme M Klobocista, Miriam D Post, Malcolm S Ross, Frederick R Ueland, Ardeshir Hakam,..., Annals of Surgical Oncology
Other
- Serum biomarkers for evaluation of an adnexal mass for epithelial carcinoma of the ovary, fallopian tube, or peritoneumUeland FR, Li AJ
http://www.uptodate.com/contents/serum-biomarkers-for-evaluation-of-an-adnexal-mass-for-epithelial-c
UpToDate, Wolters Kluwer Health - 2013-04-17
Press Mentions
UK Study Shows Combination Therapy May Potentially Improve Ovarian Cancer Patient OutcomesSeptember 28th, 2021- Preventing Cancer Recurrence with Coffee? Markey Launches Unique Clinical TrialApril 26th, 2021
- Cancer Centers Cope with COVID-19 SurgeNovember 30th, 2020
Hospital Affiliations
University of Kentucky Albert B. Chandler HospitalLexington, Kentucky
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
